For patients, visible symptoms of uveitis correlate with perceptions of worse physical health, according to a recent study. Ophthalmologist Sunil Srivastava, MD, and rheumatologists Rula Hajj-Ali, Joshua Hedrick, MD, explain the relationship between patient reported outcomes measures and disease activity in inflammatory eye disease.
The Search for Prognostic Markers in Patients with Primary Angiitis of the Central Nervous System
A new study of long-term outcomes in primary angiitis of the central nervous system suggests that mortality is significant, but long-term disability is mild. Dr. Rula Hajj-Ali describes her research efforts and the need for prognostic markers.
Immunodeficiency Diseases and the Rheumatologist: It’s Not Just About Infection
Primary immunodeficiency disorders (PID) have a growing spectrum of noninfectious complications. Vasculitis is one. Here’s what rheumatologists should take away from recent research.
CNS Granulomata in Common Variable Immunodeficiency
This case series adds to the diagnostic landscape of CNS granulomatous disease and provides an overview of the varying treatments currently in use for these rare manifestations of a rare disease.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Long-Term Outcomes for Patients with PACNS
This is the longest reported follow-up of patients with PACNS and the first evaluation of the quality of life and incidence of depression in these patients.
Training Future Rheumatologists in Vasculitis
A training infrastructure for our rheumatology fellows provides a full circle experience of evidence-based, didactic learning and its application to the direct care of patients with vasculitis.
Race Against Vision Loss in Inflammatory Eye Disease
Uveitis accounts for 10-15 percent of legal blindness in the United States. At Cleveland Clinic, multicenter collaboration, fast-track evaluation and treatment help patients avoid vision loss.
Susac Syndrome: Pooling Efforts at the Global Level Against a Newly Recognized Disease
An international collaborative study and disease registry are among an array of efforts led out of Cleveland Clinic to better understand and manage this rare autoimmune disease.
Biologic Therapies Summit: The Insights Continue Through Online CME
A comprehensive suite of 30 free CME webcasts gives you the chance to see why clinicians came from 29 states and 20 nations to attend this year’s Biologic Therapies Summit VI.
CNS Vasculitis Gets Its Due in First Major Symposium of Its Kind
This daylong pre-symposium to Cleveland Clinic’s Biologic Therapies VI Summit is the most comprehensive live CME course to date on this complex vascular inflammatory disease.